Manuka Honey: A Sweetener Your Liver Can Appreciate
Why MGO mānuka honey is a metabolically superior sweetener, the fructose science, liver enzymes, and what a PhD beekeeper eats instead.
Clinically reviewed by Kim Slemint, RN, Clinical Advisor, Tōtika Health
Originally published 11 January 2018 · Updated April 2026
Honey has been part of human diets for thousands of years. Mānuka honey has a particularly distinctive biochemical profile. This article explores what the current research says about honey and some metabolic markers; what that evidence can and cannot tell us; and why the type of sweetener you choose may have some bearing on your metabolic health, in modest and carefully qualified ways.
Why the Choice of Sweetener Has Any Relevance to Metabolic Health
The liver processes fructose almost entirely on its own. When fructose arrives in large amounts from refined sources such as high-fructose corn syrup or sucrose, it can contribute to the production of triglycerides in the liver. Over time and in the context of excess energy intake, this can be one factor in fat accumulation in liver tissue.
This does not mean that fructose from any source is harmful. Context, quantity, and the broader dietary pattern matter enormously. What the research does suggest is that the type of sweetener you use, and whether it comes with any additional bioactive compounds, may be relevant when considered as part of a whole dietary pattern. Honey has been the subject of some research in this context, precisely because it is not just sugar.
We want to be clear about the limits of this idea. Switching a sweetener does not treat or manage liver disease. If you have a liver condition, this article is not a resource for you; your medical team is. What this article addresses is a food question: is mānuka honey a more considered choice than refined sugar as an everyday sweetener, and what does the available evidence suggest?
What Makes Mānuka Honey Different from Refined Sugar
Refined white sugar is sucrose: two sugar molecules bonded together, delivering nothing beyond energy. Mānuka honey is more complex. It contains roughly 38 per cent fructose and 31 per cent glucose in free form, but alongside those sugars it carries a range of compounds that refined sugar does not.
Methylglyoxal
MGO is the compound that defines mānuka honey's unique antibacterial activity. It forms in the hive from dihydroxyacetone, which is present in high concentrations only in the nectar of Leptospermum scoparium, the mānuka plant native to New Zealand. MGO content is measured and certified by independent IANZ-accredited laboratories; at Tōtika, we use R J Hill Laboratories in Hamilton for every batch, from our Bay of Islands hives. The MGO rating on the jar reflects a verified measurement, not a marketing claim.
Polyphenols: Chrysin, Pinobanksin, and Pinocembrin
A 2024 study from the Medical University of Lodz confirmed that commercially available mānuka honey contains polyphenolic compounds including chrysin, pinobanksin, and pinocembrin, and demonstrated measurable free-radical-scavenging activity in biochemical testing [1]. This was a laboratory study; it characterised what is in the honey and how those compounds behave chemically. It did not test effects on the liver or on human health outcomes. We cite it here to describe composition, not to make clinical claims. For a deeper explanation of how MGO forms and what the grades mean, see our complete MGO science guide.
Oligosaccharides and Prebiotic Activity
Honey contains oligosaccharides that are not fully digested in the small intestine and may support the growth of beneficial gut bacteria. The relationship between gut microbiome composition and liver function is an active area of research. We discuss this below in appropriately cautious terms.
What the Human Evidence Actually Shows
This is where we want to be most careful, and most honest.
A 2023 systematic review published in Nutrients analysed 48 clinical trials on honey and human health, covering 3,655 participants across cardiovascular, metabolic, and inflammatory outcomes. The reviewers found that honey consumption was associated with more beneficial than neutral or harmful outcomes for metabolic risk factors, particularly when honey replaced other sweeteners rather than being added on top of an existing diet [2]. This is the most important qualifier in the entire evidence base: the benefit observed is a substitution benefit, not a honey-as-supplement benefit.
A 2023 meta-analysis from the University of Toronto, published in Nutrition Reviews, analysed 18 controlled feeding trials involving 1,105 participants. It found that honey intake was associated with statistically significant reductions in fasting glucose, ALT (alanine aminotransferase, a marker of liver enzyme activity), total cholesterol, LDL cholesterol, and fasting triglycerides, alongside an increase in HDL cholesterol [3]. This is notable because ALT is one of the markers clinicians use to monitor liver health. However, the researchers themselves drew a careful conclusion: the findings applied in the context of healthy dietary patterns where added sugars made up no more than 10 per cent of daily caloric intake. The lead researcher stated explicitly: "We are not saying you should start having honey if you currently avoid sugar. The takeaway is more about replacement."
What Animal and Laboratory Research Suggests: With Honest Caveats
There is a body of preclinical research on honey and liver health that is worth understanding, provided its limitations are clear.
A 2024 study published in the Journal of Food Biochemistry tested different honey samples, classified by their total phenolic content and antioxidant capacity, in a rat model of liver injury induced by carbon tetrachloride (a toxic chemical used to create controlled liver damage in laboratory animals) [4]. Honeys with higher phenolic content and antioxidant activity were associated with better protection of liver enzyme markers. The study's conclusion was that hepatoprotective effects of honey appear related to its phenolic content. This is interesting in the context of mānuka honey, which has a well-characterised polyphenol profile, but this study did not test mānuka honey specifically, and animal models of toxic liver injury are quite different from the metabolic liver conditions affecting most people.
A 2021 study in Frontiers in Immunology investigated whether monofloral honey polyphenols could improve liver markers in mice with alcohol-induced liver injury by modulating gut microbiota composition [5]. The honey tested was Triadica cochinchinensis, a Chinese medicinal plant honey, not mānuka honey. The study found positive effects on liver enzyme levels and gut bacterial composition in the animal model. We cite this study because the mechanism it investigates, specifically the relationship between honey polyphenols, gut microbiota, and liver health, is scientifically relevant to understanding why any monofloral honey might have hepatic effects. It does not constitute evidence for mānuka honey specifically, and it is animal data.
The Gut-Liver Connection: A Research Area, Not an Established Fact
The relationship between gut microbiome composition and liver health is one of the most active areas in gastroenterology research. The liver receives blood directly from the intestinal tract via the portal vein; the balance of bacterial populations in the gut influences what metabolites, inflammatory signals, and microbial byproducts the liver is exposed to.
Honey contains compounds that laboratory studies suggest may support beneficial gut bacteria. Whether this translates into measurable liver benefit in humans, at the quantities of honey a person would normally consume, has not been established. We raise this connection because it is scientifically interesting and because it represents a plausible mechanism. We do not cite it as evidence of effect.
Comparing Mānuka Honey to Other Sweeteners: What the Evidence Permits Us to Say
| Sweetener | Bioactive compounds beyond sugar | Human clinical evidence | Key caveat |
|---|---|---|---|
| Refined white sugar | None | Associated with negative metabolic outcomes at high intake | No protective compounds of any kind |
| High-fructose corn syrup | None | Associated with elevated triglycerides and liver fat at high intake | Higher free-fructose content than sugar |
| Regular multifloral honey | Polyphenols (variable), oligosaccharides | Some metabolic benefit in controlled trials when replacing other sweeteners | Polyphenol content varies widely; no MGO |
| Mānuka honey (monofloral) | Polyphenols, MGO, leptosperin, oligosaccharides | Not specifically tested in liver health trials; general honey evidence applies | More bioactives than regular honey; no human liver trials specific to mānuka |
The honest position is that the human clinical evidence for honey and metabolic markers is promising but limited, and the evidence specifically for mānuka honey in liver health is very thin. What we can say is that mānuka honey brings a richer bioactive profile to the substitution than any refined sweetener does, and that when the question is "which sweetener should I use in moderation," the science offers reasonable support for choosing honey over refined sugar.
Important Safety Information
We include this section not as a formality but because it genuinely matters.
- Infants under 12 months: All honey carries a risk of Clostridium botulinum spores. An infant's digestive system cannot neutralise these. This is an absolute contraindication; there is no safe amount of honey for a baby under one year of age.
- Diabetes or pre-diabetes: Honey raises blood glucose. It is a sugar. If you manage blood glucose medically or are at risk of diabetes, discuss any dietary change with your GP before acting on anything in this article. Mānuka honey is not a therapeutic food for diabetes.
- Diagnosed liver conditions: If you have any diagnosed liver condition, including fatty liver disease, hepatitis, or cirrhosis, the dietary decisions that matter are ones you make with your hepatologist or GP. This article is not a resource for managing those conditions.
- Bee product allergy: Honey can cause reactions in people allergic to bee stings or propolis. If you have this allergy, do not consume honey without medical advice.
- Weight management: Honey is energy-dense. Any metabolic benefit described in the research literature applies to honey replacing other sweeteners, not to honey being added to a diet that already includes significant sugar intake.
- Medications: If you take any prescription medication, particularly warfarin or drugs that affect blood glucose, speak with your pharmacist or GP before introducing honey as a regular dietary element. Honey can interact with certain medications.
Frequently Asked Questions
Is mānuka honey good for liver health?
There is no human clinical evidence that mānuka honey specifically improves liver health. There is evidence from controlled human trials that honey in general, when it replaces refined sugar as part of a healthy diet, is associated with modest reductions in ALT (a liver enzyme marker) and some other metabolic markers. Mānuka honey has a more complex bioactive profile than most other honeys, but it has not been specifically tested in human liver health trials. If liver health is a concern for you, speak with your GP.
Does mānuka honey help with fatty liver disease?
There is no human clinical evidence that mānuka honey treats or improves fatty liver disease. Some animal studies suggest that high-phenolic honey may reduce liver enzyme elevations in models of liver injury, but animal model results frequently do not translate to human benefit. Fatty liver disease requires management through diet, exercise, and medical oversight. Please speak with your GP or a dietitian.
Is mānuka honey better for you than white sugar?
As a food choice in moderation, the available evidence suggests honey may be a more considered option than refined sugar when used as a replacement. Human clinical trials suggest modest metabolic benefits when honey replaces other sweeteners, which refined sugar does not offer. This is not a claim that honey is a health food or that consuming it confers medical benefit. Honey is still a sugar.
How much mānuka honey should I eat for health benefits?
We are not in a position to give dietary recommendations, and this article does not include serving size guidance for health purposes. The human clinical trials reviewed used median doses of approximately 40g per day, but those were controlled research settings, not prescriptions. If you want personal dietary guidance, speak with a dietitian or your GP. In general terms, honey should be used in moderation as part of a varied diet.
Can I use mānuka honey if I have diabetes?
No, not without speaking to your GP or endocrinologist first. Honey raises blood glucose. Some trials have looked at honey in people with diabetes, but these were conducted under medical supervision. Please do not make any dietary change that affects your blood glucose management based on a blog article.
Is there a specific MGO grade that is best for liver or metabolic health?
There is no evidence base that allows us to recommend a specific MGO grade for liver or metabolic health. MGO grade relates to antibacterial potency, which is distinct from polyphenol content and metabolic effects. We do not provide MGO grade recommendations for health conditions.
References
- Kaźmierczak-Barańska J, Karwowski BT. The antioxidant potential of commercial Manuka honey from New Zealand: biochemical and cellular studies. Curr Issues Mol Biol. 2024;46(7):6366–6376. doi:10.3390/cimb46070380
- Palma-Morales M, Huertas JR, Rodríguez-Pérez C. A comprehensive review of the effect of honey on human health: metabolic, cardiovascular, and inflammatory aspects. Nutrients. 2023;15(13):3056. doi:10.3390/nu15133056
- Ahmed A, Tul-Noor Z, Lee D, et al. Effect of honey on cardiometabolic risk factors: a systematic review and meta-analysis. Nutr Rev. 2023;81(7):758–774. doi:10.1093/nutrit/nuac086
- Zamani Ranjbar Garmroodi B, Rajabi Moghadam M, Zarban A, et al. Hepatoprotective effects of medicinal honey: introducing a new classification based on phenolic content and antioxidant capacity. J Food Biochem. 2024;2024:4475104. doi:10.1155/2024/4475104
- Luo L, Zhang J, Liu M, et al. Monofloral Triadica cochinchinensis honey polyphenols improve alcohol-induced liver disease by regulating the gut microbiota of mice. Front Immunol. 2021;12:673903. doi:10.3389/fimmu.2021.673903
